DnB Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.2M | Buy |
19,446
+2,212
| +13% | +$1.24M | 0.03% | 338 |
|
|
2026
Q1 | $9.68M | Buy |
17,234
+746
| +5% | +$478K | 0.03% | 309 |
|
|
2025
Q4 | $11.2M | Buy |
16,488
+716
| +5% | +$488K | 0.04% | 279 |
|
|
2025
Q3 | $10.1M | Buy |
15,772
+434
| +3% | +$263K | 0.04% | 298 |
|
|
2025
Q2 | $8.23M | Buy |
15,338
+511
| +3% | +$244K | 0.03% | 293 |
|
|
2025
Q1 | $6.23M | Buy |
14,827
+152
| +1% | +$66K | 0.03% | 337 |
|
|
2024
Q4 | $6.07M | Buy |
14,675
+254
| +2% | +$111K | 0.03% | 352 |
|
|
2024
Q3 | $7.29M | Buy |
14,421
+661
| +5% | +$321K | 0.03% | 317 |
|
|
2024
Q2 | $6.7M | Sell |
13,760
-6,649
| -33% | -$3.34M | 0.03% | 300 |
|
|
2024
Q1 | $11M | Sell |
20,409
-1,941
| -9% | -$1.06M | 0.06% | 221 |
|
|
2023
Q4 | $12.4M | Buy |
22,350
+292
| +1% | +$137K | 0.06% | 219 |
|
|
2023
Q3 | $9.65M | Buy |
22,058
+195
| +0.9% | +$97.2K | 0.06% | 229 |
|
|
2023
Q2 | $11M | Sell |
21,863
-181
| -0.8% | -$86.7K | 0.06% | 219 |
|
|
2023
Q1 | $11M | Buy |
22,044
+415
| +2% | +$199K | 0.07% | 219 |
|
|
2022
Q4 | $8.82M | Buy |
21,629
+763
| +4% | +$296K | 0.06% | 242 |
|
|
2022
Q3 | $6.8M | Buy |
20,866
+7,069
| +51% | +$2.6M | 0.05% | 274 |
|
|
2022
Q2 | $4.84M | Buy |
13,797
+225
| +2% | +$91.8K | 0.03% | 340 |
|
|
2022
Q1 | $7.42M | Buy |
13,572
+224
| +2% | +$118K | 0.04% | 301 |
|
|
2021
Q4 | $8.79M | Buy |
13,348
+756
| +6% | +$475K | 0.05% | 256 |
|
|
2021
Q3 | $7.83M | Buy |
12,592
+518
| +4% | +$348K | 0.05% | 259 |
|
|
2021
Q2 | $7.63M | Sell |
12,074
-2,960
| -20% | -$1.63M | 0.05% | 266 |
|
|
2021
Q1 | $7.36M | Buy |
15,034
+4,003
| +36% | +$2.01M | 0.05% | 246 |
|
|
2020
Q4 | $5.51M | Buy |
+11,031
| New | +$4.94M | 0.05% | 247 |
|
|
2020
Q1 | – | Sell |
-17,730
| Closed | -$4.63M | – | 619 |
|
|
2019
Q4 | $4.63M | Sell |
17,730
-6,215
| -26% | -$1.64M | 0.05% | 263 |
|
|
2019
Q3 | $6.51M | Buy |
23,945
+472
| +2% | +$131K | 0.07% | 198 |
|
|
2019
Q2 | $6.46M | Buy |
23,473
+5,949
| +34% | +$1.47M | 0.07% | 197 |
|
|
2019
Q1 | $3.92M | Sell |
17,524
-1,287
| -7% | -$266K | 0.04% | 259 |
|
|
2018
Q4 | $3.5M | Buy |
18,811
+1,700
| +10% | +$349K | 0.05% | 256 |
|
|
2018
Q3 | $4.27M | Buy |
+17,111
| New | +$4.15M | 0.05% | 249 |
|
|
2018
Q1 | – | Sell |
-21,860
| Closed | -$3.42M | – | 624 |
|
|
2017
Q4 | $3.42M | Buy |
21,860
+3,500
| +19% | +$551K | 0.04% | 272 |
|
|
2017
Q3 | $2.85M | Buy |
+18,360
| New | +$2.9M | 0.04% | 278 |
|
Other funds holding IDXX
DnB Asset Management's IDXX Position: Q2 2026 in Review
DnB Asset Management increased its Idexx Laboratories (IDXX) stake by 13% in Q2 2026, buying an estimated $1.24M and bringing the position to 19,446 shares worth $10.2M. The position accounts for 0.03% of the portfolio, ranked #338.
DnB Asset Management first reported a position in IDXX in Q3 2017 and has held it in 31 quarters since. The position peaked at $12.4M in Q4 2023. 880 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- DnB Asset Management held 19,446 shares of Idexx Laboratories worth $10.2M as of Q2 2026.
- DnB Asset Management bought 2,212 Idexx Laboratories shares in Q2 2026, an estimated $1.24M.
- Idexx Laboratories made up 0.03% of DnB Asset Management's portfolio in Q2 2026, its #338 holding.
- DnB Asset Management first reported a position in Idexx Laboratories in Q3 2017 and has held it in 31 quarters since.
- DnB Asset Management's Idexx Laboratories position peaked at $12.4M in Q4 2023.
- 880 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.